Long-term mortality of patients with an alcohol-related Wernicke–Korsakoff syndrome

[EN]Aims: To characterize a series of contemporary patients with alcohol-related Wernicke’s encephalopathy (WE) or Korsakoff’s syndrome (KS) and to update the current prognosis of disease. Methods: Retrospective and prospective study of patients diagnosed with an alcohol-related WE or KS between 200...

Descripción completa

Detalles Bibliográficos
Autores: Sanvisens Bergé, Arantza, Zuluaga, Paola, Fuster, Daniel, Rivas, Inmacula, Tor, Jordi, Marcos Martín, Miguel, Chamorro Fernández, Antonio Javier, Muga Bustamante, Roberto
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2017
País:España
Institución:Universidad de Salamanca (USAL)
Repositorio:GREDOS. Repositorio Institucional de la Universidad de Salamanca
OAI Identifier:oai:gredos.usal.es:10366/154089
Acceso en línea:http://hdl.handle.net/10366/154089
Access Level:acceso embargado
Palabra clave:Wernicke–Korsakoff syndrome
Alcohol
Alcoholism
alcoholismo
Descripción
Sumario:[EN]Aims: To characterize a series of contemporary patients with alcohol-related Wernicke’s encephalopathy (WE) or Korsakoff’s syndrome (KS) and to update the current prognosis of disease. Methods: Retrospective and prospective study of patients diagnosed with an alcohol-related WE or KS between 2002 and 2011 in a tertiary hospital. Socio-demographic, alcohol use characteristics, signs and symptoms, co-morbidity and blood parameters were obtained at admission. Patients were followed up until 2013 and causes of death were ascertained through the review of charts. Results: Sixty-one patients were included (51 with WE and 10 with KS). Among patients with WE, 78% were men and age at diagnosis was 57 years (interquartile range (IQR): 49–66). Twenty-three percent fulfilled the classic WE triad. Regarding Caine’s criteria for WE, 70.6% presented with at least two out of four signs or symptoms. Median follow-up of patients with WE syndrome was 5.3 years (IQR: 2.6–8.8), the cumulated mortality was 45% and death rate of 7.4 × 100 person-years (95% confidence interval (CI): 4.8–10.9). Overall, 50% of patients would be expected to die within 8 years of WE episode and main causes of death included serious bacterial infections (44.5%) and cancer (33.3%). Conclusions: Survival of patients with an alcohol-related Wernicke–Korsakoff syndrome is poor; pursuing treatment of alcohol use disorder and early diagnosis of thiamine deficiency is a priority for improving clinical outcomes.